Search the Newsreel

Form 8K Intensity Therapeutics Inc For: 11 August By Investing.com

This article reports that Intensity Therapeutics Inc. filed a Form 8K on August 11, 2026. The Form 8K is a crucial document used by public companies to notify investors of significant events that shareholders should know about. No specific details about the content of …

TME Stock Dips As Traders Eye Key Support Zone

Tencent Music Entertainment Group (TME) stock has dipped by over 11% due to concerns about weakening user growth, causing traders to watch the $8.50–$8.70 support zone. Despite the dip, the company shows strong fundamentals with substantial cash reserves, manageable debt, and solid returns, making …

Tencent Music’s Q2 Revenue Tops $1.3 Billion on Subscription Growth, Ximalaya Acquisition

Tencent Music Entertainment Group (TME) reported a nearly 6% rise in Q2 revenues to $1.32 billion, driven by double-digit growth in music services and the acquisition of podcast platform Ximalaya. The Ximalaya acquisition contributed $60 million in revenue, while membership services revenue increased by …

Tencent Music Entertainment Group (NYSE:TME) Shares Gap Down - Should You Sell?

Tencent Music Entertainment Group (NYSE:TME) gapped down before market open, with shares trading at $8.9250 after closing at $9.90. Analyst sentiment for TME is mixed, averaging to a "Hold" rating with a consensus price target of $21.44, though some firms have recently lowered their …

Intensity Therapeutics Q2 Results: EPS loss narrows 67% YoY

Why Is Tencent Music Stock Sinking Tuesday?

Tencent Music Entertainment slips as investors weigh earnings quality after quarterly report

Tencent Music Entertainment (TME) stock fell 9.7% after its second-quarter earnings release, as investors focused on the quality of growth rather than headline results. This reaction was likely influenced by underlying softness in the legacy business, continued weakness in social entertainment, and complexities from …

Tenable Currently Up 10 Consecutive Days, On Pace for Record Winning Streak -- Data Talk

Tenable Holdings, Inc. (TENB) is experiencing a significant winning streak, currently up 10 consecutive days and trading at $38.06, an increase of 3.71%. This performance places the company on pace for its longest winning streak on record and marks a 21.33% gain over this …

Tencent Music shares slide after Q2 results despite beat

Tencent Music Entertainment Group (TME [https://seekingalpha.com/symbol/TME]) shares fell 9% following the release of its second-quarter results [https://seekingalpha.com/news/4630500-tencent-music-entertainment-non-gaap-epads-of-025-beats-by-001-revenue-of-132b-beats-by-20m], as investors appeared to look beyond a modest revenue and earnings beat and focused on slowing growth across parts of the business. The Chinese music and audio …

Tencent's Second-Quarter Revenue Growth Slows Sequentially; Shares Slump

(Article updated to write out the full company name in the headline.) Tencent Music Entertainment PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have …

Tencent’s WorkBuddy sparks AI turnaround hopes after stock rout

(Bloomberg) -- Tencent Holdings Ltd.'s early success with WorkBuddy may give the Chinese Internet giant a chance to catch up after lagging peers in the artificial intelligence race for the past few years. Most Read from Bloomberg China Unleashes $28 Trillion Capital Markets to …

Ohio regulators want to fine FirstEnergy for its grid failures: Today in Ohio

Ohio regulators are proposing a $3 million fine and six corrective actions against FirstEnergy subsidiary, Cleveland Electric Illuminating Company (CEI), for repeated power outages in Lakewood due to aging infrastructure. The Public Utilities Commission of Ohio (PUCO) found probable violations of state law, with …

Tenet Healthcare (THC) Just Flashed Golden Cross Signal: Do You Buy?

Tenet Healthcare Corporation (THC) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, THC's 50-day simple moving average crossed above its 200-day simple moving average, known as a "golden cross." A golden cross …

Tencent Music Entertainment Group: Q2 2026 revenue rose 6% to RMB 8.9B, with strong IP and Ximalaya-driven growth

Tencent Music Entertainment Group reported a 6% revenue growth in Q2 2026, reaching RMB 8.9 billion, primarily driven by music services and the integration of Ximalaya. The company saw strong performance in IP-related offerings, live events, and merchandise, while maintaining a stable gross margin. …

Centene (NYSE:CNC) Upgraded at Argus

Argus upgraded Centene (NYSE:CNC) from a "hold" to a "buy" rating, setting an $80 price target, which implies a 20.3% upside. This upgrade follows strong quarterly results where Centene reported $2.51 EPS against an expected $1.09, and revenue of $53.58 billion, a 9.9% increase …

China’s Tencent Music Reports $1.32 Billion in Q2 Revenue as Ximalaya Integration Marks New Audio Push

Informe de resultados de Tencent Music Q2 2026: ingresos superan previsiones, pero el BPA decepciona

Argus upgrades Centene stock rating to buy on margin outlook By Investing.com

Argus has upgraded Centene Corp. (NYSE:CNC) shares from hold to buy, setting an $80.00 price target. The upgrade is based on Centene's strong position as the largest Medicaid managed care organization in the U.S. and expectations for restored profitability due to bottoming Medicaid margins …

Sidoti Issues Negative Outlook for Tennant Earnings

TENAX THERAPEUTICS INC : WILLIAM BLAIR CUTS TO MARKET PERFORM RATING

William Blair has downgraded its rating for Tenax Therapeutics Inc. (TENX.O) to "Market Perform." This change in rating suggests a revised outlook on the company's stock performance. The article does not provide specific reasons for the downgrade but notes the financial analyst action.

Evercore ISI Downgrades Tenax Therapeutics to In Line From Outperform, Adjusts PT to $5 From $39

Evercore ISI has downgraded Tenax Therapeutics (TENX) from Outperform to In Line and significantly reduced its price target from $39 to $5. This downgrade follows similar actions by other firms, coming after Tenax Therapeutics announced disappointing topline results from its Phase 3 LEVEL clinical …

CENTENE CORP : ARGUS RESEARCH RAISES TO BUY FROM HOLD

Argus Research has upgraded its rating on Centene Corp (CNC.N) from "Hold" to "Buy." The report, provided by Reuters, indicates a positive outlook from the research firm regarding the healthcare enterprise.

INTENSITY THERAPEUTICS, INC. Q2 2026: Net income $(3.0M), EPS $(1.11) — 10-Q Summary

INTENSITY THERAPEUTICS, INC. reported a net loss of $(3.0M) for Q2 2026, an increase from $(2.5M) in Q2 2025, with a diluted loss per share of $(1.11). The company remains pre-revenue but has made progress in its clinical programs, including initiating Phase 3 and …

Tencent Music (NYSE: TME) grows Q2 revenue, boosts cash and buybacks

Tenax Therapeutics’ stock crashes on Phase III trial failure

Tenax Therapeutics' stock plunged by nearly 90% after its Phase III LEVEL trial for TNX-103, an oral therapy for pulmonary hypertension associated with heart failure, failed to meet its primary and key secondary endpoints. Despite the overall failure, a prespecified subgroup analysis showed a …

Tenaris (TS) outlines Q2 2026 results and outlook on investor conference call

Tenaris S.A. filed a Form 6-K report detailing its Q2 2026 results audio conference held on August 6, 2026. CEO Gabriel Podskubka and senior management discussed the company's performance, market background, and outlook with investors and analysts. The company, a leading global supplier of …

Tencent Music Entertainment Group earnings missed by ¥0.05, revenue topped estimates

Tencent Music Entertainment Group (TME) reported second-quarter earnings per share of ¥1.57, missing analyst estimates by ¥0.05. However, the company's revenue of ¥8.93 billion surpassed the consensus estimate of ¥8.79 billion. TME's stock has seen a 15.12% increase in the last three months but …

Centene Corp (CNC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Centene Corp (CNC), noting its current price momentum score of 4.22 and its trading range between resistance at $71.41 and support at $59.70. It details various technical indicators like MACD, RSI, and moving averages, with a summary …

Tencent Music Entertainment (TME) Looks 36.7% Undervalued on GF Value™

TENAX THERAPEUTICS INC : LEERINK PARTNERS CUTS TARGET PRICE TO $4 FROM $26

LEERINK PARTNERS has significantly cut its target price for TENAX THERAPEUTICS INC (TENX.O) from $26 to $4. This adjustment in the target price indicates a revised outlook for the company by the financial firm. The article, sourced from Reuters, focuses solely on this financial …

Tencent Music Entertainment Group no alcanza por 0,05¥ las previsiones de BPA en el segundo trimestre del año

Tencent Music Repurchases 43.5M American Depositary Shares for About $400M

Tencent Music Entertainment Non-GAAP EPADS of $0.25 beats by $0.01, revenue of $1.32B beats by $20M

* Tencent Music Entertainment press release [https://seekingalpha.com/pr/20614025-tencent-music-entertainment-group-announces-second-quarter-2026-unaudited-financial-results] (TME [https://seekingalpha.com/symbol/TME]): Q2 Non-GAAP EPADS of $0.25 beats by $0.01. * Revenue of $1.32B (+11.9% Y/Y) beats by $20M. * Revenues from music related services were RMB7.61 billion (US$1.12 billion), representing 11.0% year-over-year growth. * Revenues from …

Tencent Music Entertainment Group Announces Second Quarter 2026 Unaudited Financial Results

SHENZHEN, China, Aug. 11, 2026 /PRNewswire/ -- Tencent Music Entertainment Group ("TME," or the "Company") (NYSE: TME and HKEX: 1698), the leading all-in-one music and audio entertainment platform in China, today announced its unaudited financial results for the second quarter ended June 30, 2026. …

Tenaya Therapeutics, Inc. (NASDAQ:TNYA) Given Average Recommendation of "Moderate Buy" by Brokerages

Tenaya Therapeutics (NASDAQ:TNYA) has received a consensus "Moderate Buy" rating from seven brokerages, with an average 12-month price target of $4.00. Despite this bullish sentiment, the company recently reported a quarterly loss of $0.20 per share and revenue of $1.11 million, both missing analyst …

Press Release: Tencent Music Entertainment Group Announces Second Quarter 2026 Unaudited Financial Results

Tencent Music Entertainment Group (TME) announced its unaudited financial results for the second quarter of 2026. This press release details the company's financial performance during this period. The full document would provide specific figures and business highlights.